Citenazone

HIV-1 inhibitor: inhibition of HIV replication:.

VEGFR2 kinase inhibitors.

inhibiting HIV-1 replication.

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt:0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt:0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt:0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt:0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt:0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt:0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate